Jennifer Stevens
Fortune : 262 694 $ au 30/06/2026
Fortune : 262 694 $ au 30/06/2026
Jennifer L.
Stevens is currently Chief Regulatory Officer at TriSalus Life Sciences, Inc. since 2022.
Formerly, Ms. Stevens was Head-US Oncology Hub Regulatory Affairs at EMD Serono, Inc. from 2016 to 2021, Regulatory Counsel at the US Food & Drug Administration from 2008 to 2012, and Partner at Kirkland & Ellis LLP.
Ms. Stevens completed graduate studies at George Washington University and undergraduate studies at the University of Illinois.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/03/2026 | 57 735 ( 0,09% ) | 262 694 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Conseiller Juridique Général | 01/03/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/03/2021 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Conseiller Juridique Général | 01/12/2012 |
Kirkland & Ellis LLP
Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kirkland & Ellis LLP
Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national